戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 xpressing PrP linked to Gerstmann-Straussler Scheinker syndrome, and the failure of gene-targeted mic
2                         Gerstmann-Straussler-Scheinker (GSS) disease is a dominantly inherited, human
3 ss molecules that cause Gerstmann-Straussler-Scheinker (GSS) disease.
4 omain implicated in the Gerstmann-Straussler-Scheinker (GSS) mutation (P102L).
5 lly associated with the Gerstmann-Straussler-Scheinker (GSS) phenotype, also shows marked clinical an
6 ngiopathy (PrP-CAA) and Gerstmann-Straussler-Scheinker (GSS) syndrome.
7 lmark features of human Gerstmann-Straussler-Scheinker (GSS) syndrome.
8 on disease [also termed Gerstmann-Straussler-Scheinker (GSS) syndrome] with unusual features such as
9                         Gerstmann-Straussler-Scheinker disease (GSS) is an inherited neurodegenerativ
10                         Gerstmann-Straussler-Scheinker disease (GSS) is characterized by the accumula
11 ogical phenotype of the Gerstmann-Straussler-Scheinker disease (GSS) variant linked to the codon 102
12 g(PrP-A116V) mice model Gerstmann-Straussler-Scheinker disease (GSS), a genetic prion disease charact
13 ations corresponding to Gerstmann-Straussler-Scheinker disease (P102L), Creutzfeld-Jakob disease (E20
14 al profile of a case of Gerstmann-Straussler-Scheinker disease associated with a novel prion protein
15 athologically confirmed Gerstmann-Straussler-Scheinker disease displaying a somewhat unusual constell
16 uman brain carrying the Gerstmann-Straussler-Scheinker disease Q217R mutation.
17               Whereas a Gerstmann-Straussler-Scheinker disease version of PrP with eight extra octare
18 veloped a cell model of Gerstmann-Straussler-Scheinker disease, a neurodegenerative condition charact
19 or was observed for the Gerstmann-Straussler-Scheinker disease-associated F198S mutant, in which case
20 ore akin to subtypes of Gerstmann-Straussler-Scheinker disease.
21 ted conditions, such as Gerstmann-Straussler-Scheinker disease.
22 ssociated with familial Gerstmann-Straussler-Scheinker disease.
23 at are pathognomonic of Gerstmann-Straussler-Scheinker disease.
24 Jakob disease (CJD) and Gerstmann-Straussler-Scheinker F198S disease brains all have an intact C1 cle
25 loss, by expressing the Gerstmann-Straussler-Scheinker haplotype Q217R-129V in human neuroblastoma ce
26          Importantly, a Gerstmann-Straussler-Scheinker mutation carrier in the asymptomatic phase and
27 familial prion disease (Gerstmann-Straussler-Scheinker P102L).
28                         Gerstmann-Straussler-Scheinker syndrome (GSS) is a genetic prion disease typi
29 l insomnia (FFI) n = 9, Gerstmann-Straussler-Scheinker syndrome (GSS)) n = 4), patients with Alzheime
30 utzfeldt-Jakob disease, Gerstmann-Straussler-Scheinker syndrome (GSS), and fatal familial insomnia.
31 limited to variant CJD, Gerstmann-Straussler-Scheinker syndrome and fatal familial insomnia.
32 e genetic prion disease Gerstmann-Straussler-Scheinker syndrome can arise from point mutations of pro
33 Jakob disease (CJD) and Gerstmann-Straussler-Scheinker syndrome have been attributed to particular in
34 utations causing CJD or Gerstmann-Straussler-Scheinker syndrome, 6 had positive and 2 had negative RT
35  present with classical Gerstmann-Straussler-Scheinker syndrome, a slowly progressive cerebellar atax
36 dt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker syndrome, and fatal familial insomnia (FFI) wh
37 116V is associated with Gerstmann-Straussler-Scheinker syndrome, but no accumulation of PrP(Sc) is de
38 sified as familial CJD, Gerstmann-Straussler-Scheinker syndrome, or fatal familial insomnia.
39 ase P102L, historically Gerstmann-Straussler-Scheinker syndrome, originates from central England, wit
40 feldt-Jakob disease and Gerstmann-Straussler-Scheinker syndrome.
41 man prion disease named Gerstmann-Straussler-Scheinker syndrome.
42 s mutation results in a Gerstmann-Straussler-Scheinker-like disease with extensive PrP amyloid deposi
43 riant associated with a Gerstmann-Straussler-Scheinker-like prion disease) spontaneously forms amyloi
44                Shorter, Gerstmann-Straussler-Scheinker-like PrP(res) fragments are also present.
45 ic residues such as the Gerstmann-Straussler-Scheinker-linked leucines can promote the in vitro forma

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。